2023 SGBCC Expert Voting: Radiotherapy

2023 SGBCC Expert Voting: Radiotherapy

The 18th St.Gallen International Breast Cancer Conference (SGBCC 2023) took place in Vienna, known as the "City of Music", from March 15th to 18th, 2023, local time. SGBCC brought together breast cancer opinion leaders from all over the world to discuss and vote on the most cutting-edge and controversial topics regarding early-stage breast cancer treatment. This culminates in the St.Gallen early-stage breast cancer international expert consensus, which is updated every two years. On the last day of the conference, the expert voting was the highlight. 
2023 SGBCC Expert Voting: Endocrine Therapy and Chemotherapy Decision for ER-Positive Breast Cancer

2023 SGBCC Expert Voting: Endocrine Therapy and Chemotherapy Decision for ER-Positive Breast Cancer

The 18th St.Gallen International Breast Cancer Conference (SGBCC 2023) was held in Vienna, the "World Music Capital," from March 15 to 18, 2023. SGBCC gathered breast cancer opinion leaders from around the world to discuss and vote on the most cutting-edge and controversial topics in early breast cancer diagnosis and treatment, forming an updated St.Gallen International Expert Consensus on Early Breast Cancer every two years. On the final day of the conference, expert voting took center stage. Oncology Frontier  has compiled expert votes on two topics: adjuvant endocrine therapy and chemotherapy decisions for ER-positive breast cancer.
2023 SGBCC Expert Voting: Pathology, Genes, DCIS, Male Breast Cancer

2023 SGBCC Expert Voting: Pathology, Genes, DCIS, Male Breast Cancer

The 18th St.Gallen International Breast Cancer Conference (SGBCC 2023) was held in Vienna, the "City of Music", from March 15 to 18, 2023 local time. SGBCC gathered breast cancer opinion leaders from all over the world to discuss and vote on the most cutting-edge and controversial topics related to early-stage breast cancer treatment. This forms the St.Gallen Early Breast Cancer International Expert Consensus, which is updated every two years. "Oncology Frontier" has compiled expert votes on topics related to early breast cancer's pathology, genes, DCIS, and male-related issues. Let's experience the St.Gallen atmosphere of early breast cancer treatment decision-making.
2023 SGBCC Expert Voting: HER2 Positive, BRCA Associated,  Bone Modifying Therapy, Molecular Diagnosis

2023 SGBCC Expert Voting: HER2 Positive, BRCA Associated,  Bone Modifying Therapy, Molecular Diagnosis

The 18th St.Gallen International Breast Cancer Conference (SGBCC 2023) was held in Vienna, known as the "Capital of World Music", from March 15th to 18th, 2023 local time. On the last day of the conference, the highlight was the expert voting session. Oncology Frontier  has  compiled expert voting on the treatment of HER2 positive breast cancer, BRCA Associated treatment,  Bone Modifying Therapy , oligo-metastatic disease, and molecular diagnosis topics. Additionally, a selection of these topics was presented for readers to vote on, allowing them to immerse themselves in the St.Gallen atmosphere of early breast cancer treatment decision-making.
SGBCC 2023 Expert Voting: Surgical Treatment

SGBCC 2023 Expert Voting: Surgical Treatment

The 18th St. Gallen International Breast Cancer Conference (SGBCC 2023) took place in Vienna, the "City of Music," from March 15th to 18th, 2023. SGBCC gathered breast cancer opinion leaders from around the world to discuss and vote on the latest and most controversial topics in early breast cancer diagnosis and treatment, culminating in the biennial St. Gallen International Expert Consensus on Early Breast Cancer. On the final day of the conference, the expert voting session took center stage. Oncology Frontier has  compiled  the following summary of the expert votes on surgical treatment.
2023 SGBCC Expert Voting: Early Treatment Decisions for Triple-Negative Breast Cancer

2023 SGBCC Expert Voting: Early Treatment Decisions for Triple-Negative Breast Cancer

The 18th St. Gallen International Breast Cancer Conference (SGBCC 2023) was held in Vienna, the "City of Music," from March 15 to 18, 2023. SGBCC brought together breast cancer opinion leaders from around the world to discuss and vote on the most cutting-edge and controversial topics in the diagnosis and treatment of early-stage breast cancer. This resulted in the updated St. Gallen International Expert Consensus on Early Breast Cancer every two years.